Institutional investors hold 77.6% of DocuSign’s outstanding shares, signaling strong confidence from endowments, hedge funds and large money managers in the company’s long-term prospects. Insiders account for 1.0% of shares, indicating limited internal trading activity relative to total float.

Among 22 brokerage firms covering DocuSign, six recommend buying and 16 recommend holding, resulting in an average rating of “Hold.” The consensus price target stands at $85.13, implying a potential upside of 23.7% from the current trading range and reflecting cautious optimism about the company’s growth trajectory.

For the most recent fiscal year, DocuSign generated $2.98 billion in revenue and net income of $1.07 billion, corresponding to earnings per share of $1.43. Its net margin of 9.57%, return on equity of 15.02% and return on assets of 7.55% outpace many peers in the digital signature space. At 4.63 times trailing revenue and 48.12 times trailing earnings, the stock trades at premium multiples justified by its market leadership and recurring subscription model.

In the latest quarter, Allspring Global Investments cut its DocuSign stake by 54.0%, selling 41,270 shares and reducing its position to 35,112 shares valued at $2.42 million. Other institutions such as Twin Peaks Wealth Advisors and Sumitomo Mitsui Financial Group initiated new positions, while insiders sold a combined 45,542 shares worth approximately $3.09 million, representing a 3.0% ownership reduction by director James A. Beer and an 8.0% reduction by CRO Paula Hansen.